RH125

· Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RH125, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors [EARLY_Phase 1]

See pricing